U.S. FDA Limits Use of Johnson & Johnson COVID-19 Vaccine Due to Blood Clot Risk

The U.S. Food and Drug Administration (FDA) announced on May 5 local time that due to the risk of blood clots after vaccination, the use of the Johnson & Johnson COVID-19 vaccine will be restricted, allowing only those who cannot or do not want to receive other COVID-19 vaccines to be vaccinated with the Johnson & Johnson vaccine. (Reported by CCTV reporter Zhaomiao Zhao)